King Khaled Eye Specialist Hospital and research Center (KKESH) is a nonprofit Organization and leading tertiary provider in Eye specialized healthcare in the Kingdome of Saudi Arabia.
Cure ADOA Foundation
The Cure ADOA Foundation was established by and for patients with autosomal dominant optic atrophy, ADOA and ADOS-plus We are a recognized patient organization and also a non-profit organization with an official status and quality mark. Our mission is to financially support scientific research into ADOA, so that the treatment and cure of ADOA can be made possible. To achieve this, we want to promote ADOA awareness both nationally and internationally. Collaboration is crucial. We seek interaction with doctors, researchers, the pharmaceutical industry and patient organizations abroad. The Cure ADOA Foundation has four main goals that are being actively worked on. 1. Raise money for scientific research to promote the treatment and cure of ADOA 2. Raise awareness on ADOA 3. Promote interaction between ADOA patients, physicians, researchers, the pharmaceutical industry, and international patient organizations 4. To be a trusted place for ADOA patients and their loved ones
Asia-Pacific Academy of Ophthalmology
The Asia-Pacific Academy of Ophthalmology (APAO) is a supranational organization that welcomes participation from national, territorial, and subspecialty-based ophthalmic societies in the Asia-Pacific. As of April 2025, the APAO membership boasts 27 national/ territorial societies and 12 subspecialty societies. Together, we represent almost 120,000 ophthalmologists across the region, accounting for approximately 59% of the global ophthalmology community. With a mission to promote the science and art of ophthalmology, we strive to eliminate preventable blindness in the region through teaching, research and service. We also organize an annual congress and publish the Asia-Pacific Journal of Ophthalmology to foster international professional collaborations.
ACollaboratory America Inc
ACollaboratory Inc. is a global medical device company specializing in premium injection solutions. Our portfolio includes STERiJECT™ needles, STERiGLIDE™ cannulas, and THE INViSIBLE NEEDLE, trusted by clinicians and pharmaceutical partners in 30+ countries. With over 80 years of precision‑manufacturing heritage and deep R&D and regulatory expertise, we operate at the intersection of clinical science and innovation. Our global network spans Japan, the Netherlands, the United Kingdom, Australia, China, Canada, and the United States. Supported by more than 500 professionals worldwide, our products serve ophthalmology, aesthetics, fertility, pain management, vaccinations, dental, and interventional medicine. ACollaboratory is committed to elevating the global standard of injectable care through continuous innovation. | ACollaboratory represents a new model for medical innovation — one that unites science, engineering, and care delivery to improve how therapies are experienced. By introducing STERiJECT products to the United States, ACollaboratory continues its legacy of engineering excellence while fostering an environment where ideas and expertise can truly work together